|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Leiomyosarcoma of the adrenal vein: a novel approach to surgical resection显示文摘 | Wang TS Ocal IT Salem RR | 2007 | World J Surg Oncol2007，5，： | 1 |
| 2 | Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met,matriptase,and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer 显示文摘 | Kang JY Dolled-Fithart M Ocal IT | 2003 | Cancer Res2003，63，5： | 1 |
| 3 | Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met,matriptase ,and hepatocyte growth factor activator inhibitor 1 in the progression of node-negtive breast cancer显示文摘 | Kang JY Dolled-Filhart M Ocal IT | 2003 | Cancer Res2003，63，5： | 1 |
| 4 | Special variants of dif- ferentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer显示文摘 | Carling T Ocal IT Udelsman R | 2007 | World J Surg2007，31，5： | 1 |
| 5 | Leiomyosar ctn ma of the adrenal vein:an novel approach to surgical resection 显示文摘 | Wang rPS Ocal IT Salem RR | 2007 | World J Surg On- col2007，5，： | 1 |
| 6 | Beta-catenin and p53 analyses of a breast carcinoma tissue microarray 显示文摘 | Chung GG Zerkowski MP Ocal IT | 2004 | Cancer2004，100，10： | 1 |
| 7 | Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer显示文摘 | Sullivan CA Ghosh S Ocal IT | 2009 | Hum Pathol2009，40，2： | 1 |
| 8 | Beta-Catenin and p53 analyses of a breast carcinoma tissue microarray显示文摘 | Chung GG Zerkowski M P Ocal IT | 2004 | Cancer2004，100，10： | 1 |
| 9 | Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met,matriptase,and hepatocyte growth factor activator inhibitor 1 in the progression of mole-egative brest cancer显示文摘 | Kang JY Dolled FM Ocal IT | 2003 | Cancer Res2003，63，5： | 1 |
| 10 | Tissue microarray analysis of hepatocyteg Growth factor/met pathway components reveals a role for Met, rnatriptase, and hepatocyte growth factor activator inhibitor1 in the progression of nodenegative Breast显示文摘 | Kang JY Dolled-filhart M Ocal IT | 2003 | Cancer Research2003，63，5： | 1 |
| 11 | Tissue microarray analysis of hepatocyte growth factor/met pathway components reveals a role for met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer显示文摘 | Kang JY Dolled-Filhart M Ocal IT | 2003 | Cancer Res2003，63，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员